Esophagitis as a complication of the combination of lenvatinib and pembrolizumab for advanced endometrial cancer: A case report

• Main Authors: Massine Fellouah (Author), Marie-Hélène Auclair (Author), Suzanne Fortin (Author), Jérémie Berdugo (Author), Lara de Guerké (Author)
• Format: Book
• Published: Elsevier, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Pembrolizumab is a monoclonal antibody targeting the programmed cell death protein 1 (PD-1). It is used in the management and treatment of various oncologic conditions. To name a few: refractory and advanced melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell carcin...